MSB 2.17% $1.13 mesoblast limited

Mesoblast in Freefall, page-657

  1. 3,856 Posts.
    lightbulb Created with Sketch. 1314
    @Goldenwings

    I'm not a scientist, just someone who reads when not out in the bush.

    I think you are interpreting the statement in an interesting way.

    remestemcel-L significantly improved respiratory and functional clinical outcomes in patients with chronic obstructive pulmonary disease (COPD) and elevated levels of the inflammatory biomarker C-reactive protein (CRP).

    Take this part of the sentence as 2 halves;

    1/ remestemcel-L significantly improved respiratory and functional clinical outcomes
    2/ in patients with chronic obstructive pulmonary disease (COPD) and elevated levels of the inflammatory biomarker C-reactive protein (CRP).

    So, who did remestemcel-L improve outcomes for?

    in patients with chronic obstructive pulmonary disease (COPD) and elevated levels of the inflammatory biomarker C-reactive protein (CRP).

    Is that clearer?
    Last edited by Treed: 11/06/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.